(Q24672964)

English

Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection

scientific article

Statements

Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection (English)
0 references
Patrick F Smith
0 references
Abayomi Ogundele
0 references
Alan Forrest
0 references
John Wilton
0 references
Karl Salzwedel
0 references
Judy Doto
0 references
Graham P Allaway
0 references
David E Martin
0 references
October 2007
0 references
51
0 references
10
0 references
3574-81
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit